Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Woodcock: Do Not Do The Wrong Study, Even If Against US FDA Advice
Jun 19 2025
•
By
Sarah Karlin-Smith
Janet Woodcock advises sponsors to do the right trial, even if the FDA says differently.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from R&D